부산대학교 도서관

Focal therapy is emerging as an alternative to active surveillance for the management of low-risk prostate cancer in carefully selected patients. The ideal patient group and an accurate method to localize cancer in the prostate is yet to be agreed upon the optimal ablative technique unknown. HIFU have enabled precision ablation to be delivered to almost millimeter accuracy. Early studies evaluating focal therapy have found a lower morbidity with acceptable short- to medium-term cancer control rates. More data from large trials on the safety and efficacy of focal therapy are required before this approach can be recommended in men with prostate cancer. Focal therapy appears to be a logical alternative to radical treatment and active surveillance, potentially combining cancer control and minimal morbidity.